Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$0.84 - $1.43 $492 - $837
-586 Reduced 0.88%
65,762 $76,000
Q2 2023

Aug 11, 2023

SELL
$0.83 - $1.12 $23,615 - $31,867
-28,453 Reduced 30.01%
66,348 $58,000
Q1 2023

May 15, 2023

BUY
$0.91 - $1.69 $451 - $838
496 Added 0.53%
94,801 $97,000
Q4 2022

Feb 13, 2023

SELL
$1.09 - $2.04 $389 - $728
-357 Reduced 0.38%
94,305 $118,000
Q3 2022

Nov 14, 2022

BUY
$1.55 - $3.01 $1,801 - $3,497
1,162 Added 1.24%
94,662 $152,000
Q2 2022

Aug 12, 2022

SELL
$1.39 - $3.12 $438,536 - $984,341
-315,494 Reduced 77.14%
93,500 $184,000
Q1 2022

May 13, 2022

SELL
$2.6 - $4.17 $45,247 - $72,570
-17,403 Reduced 4.08%
408,994 $1.24 Million
Q4 2021

Feb 08, 2022

BUY
$3.64 - $7.78 $11,436 - $24,444
3,142 Added 0.74%
426,397 $1.55 Million
Q3 2021

Nov 15, 2021

SELL
$6.01 - $8.71 $130,038 - $188,458
-21,637 Reduced 4.86%
423,255 $3.33 Million
Q2 2021

Aug 13, 2021

BUY
$6.02 - $9.64 $309,572 - $495,727
51,424 Added 13.07%
444,892 $3.23 Million
Q1 2021

May 12, 2021

SELL
$9.17 - $14.8 $384,406 - $620,416
-41,920 Reduced 9.63%
393,468 $3.7 Million
Q4 2020

Feb 11, 2021

SELL
$8.92 - $13.29 $69,799 - $103,994
-7,825 Reduced 1.77%
435,388 $4.92 Million
Q3 2020

Nov 16, 2020

SELL
$9.94 - $16.59 $153,225 - $255,734
-15,415 Reduced 3.36%
443,213 $4.74 Million
Q2 2020

Aug 14, 2020

BUY
$12.07 - $19.34 $1.6 Million - $2.56 Million
132,239 Added 40.52%
458,628 $6.97 Million
Q1 2020

May 14, 2020

BUY
$12.5 - $22.04 $79,500 - $140,174
6,360 Added 1.99%
326,389 $5.07 Million
Q4 2019

Feb 14, 2020

SELL
$11.42 - $22.19 $190,531 - $370,217
-16,684 Reduced 4.95%
320,029 $6.62 Million
Q3 2019

Nov 13, 2019

BUY
$14.74 - $22.28 $1.18 Million - $1.79 Million
80,215 Added 31.27%
336,713 $6.1 Million
Q2 2019

Aug 13, 2019

BUY
$18.35 - $30.34 $1.28 Million - $2.11 Million
69,669 Added 37.29%
256,498 $5.02 Million
Q1 2019

May 13, 2019

BUY
$19.76 - $29.57 $108,047 - $161,688
5,468 Added 3.01%
186,829 $5.18 Million
Q4 2018

Feb 12, 2019

BUY
$18.39 - $26.3 $1.11 Million - $1.58 Million
60,163 Added 49.64%
181,361 $4.06 Million
Q3 2018

Nov 14, 2018

BUY
$15.54 - $22.86 $165,003 - $242,727
10,618 Added 9.6%
121,198 $2.77 Million
Q2 2018

Aug 14, 2018

BUY
$16.49 - $21.55 $1.82 Million - $2.38 Million
110,580 New
110,580 $2.26 Million

Others Institutions Holding FIXX

About Homology Medicines, Inc.


  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.